Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,969.00
Ask: 1,970.00
Change: -5.00 (-0.25%)
Spread: 1.00 (0.051%)
Open: 1,984.00
High: 1,984.00
Low: 1,962.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Fri, 20th Aug 2021 08:10

(Alliance News) - Softbank-backed investment manager Fortress hasn't abandoned yet its effort to buy Wm Morrison Supermarkets, despite the UK grocer late Thursday agreeing to a new GBP7 billion offer from rival bidder Clayton, Dubilier & Rice.

Fortress on Friday asked Morrisons shareholders to take no action on the new CD&R bid, saying it is "considering its options" with respect to the all-cash offer it made at the start of July and increased at the start of August. It said it will make a further announcement "in due course".

The new CD&R offer has been unanimously accepted by the board of the grocer, and directors have said shareholders should vote in favour of the takeover at a meeting due in early October. This means Morrisons has withdrawn its recommendation for investors to accept a previous GBP6.7 billion takeover deal from a consortium led by Fortress.

Last week, CD&R was given an extended deadline until this afternoon by takeover regulators to say whether it wants to make a new offer for Morrisons, or to walk away.

CD&R had originally been turned down by the Morrisons board over a potential GBP5.5 billion bid. In June, the board said the offer "significantly undervalued Morrisons and its future prospects". Since then CD&R had been pondering whether it should increase its bid for the supermarket chain.

Morrisons shares were up 4.6% at 292.08 pence early Friday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.2% at 7,074.38

----------

Hang Seng: down 1.9% at 24,830.72

Nikkei 225: closed down 1.0% at 27,013.25

DJIA: closed down 66.57 points, or 0.2%, at 34,894.12

S&P 500: closed up 5.53 points, or 0.1%, at 4,405.80

Nasdaq Composite: closed up 15.87 points, or 0.1%, at 14,541.79

----------

EUR: soft at USD1.1679 (USD1.1685)

GBP: down at USD1.3614 (USD1.3666)

USD: down at JPY109.64 (JPY109.75)

Gold: up at USD1,787.40 per ounce (USD1,781.65)

Oil (Brent): up at USD66.62 a barrel (USD66.10)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Friday's Key Economic Events still to come

1100 BST Ireland wholesale price index

----------

Retail sales unexpectedly declined in the UK in July, data from the Office of National Statistics showed. Retail sales volumes fell by 2.5% in July from June, which is significantly below the market consensus cited by FXStreet of a 0.4% gain. On the year before, July's sales rose 2.4%, again well short of market consensus, which had predicted a 6% rise. The ONS also noted July's sales are up 5.8% on the pre-coronavirus pandemic level in February 2020. Food store sales volumes fell by 1.5% in July, following an increase in the previous month, when sales had been boosted by the start of the Euro 2020 football championship. Non-food stores saw a fall of 4.4% in sales in July from June, driven by falls in second-hand goods stores and computer and telecoms equipment stores.

----------

BROKER RATING CHANGES

----------

JPMORGAN RAISES HIKMA PHARMACEUTICAL TARGET TO 3000 (2700) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES BABCOCK INTERNATIONAL TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - PRICE TARGET 410 (260) PENCE

----------

COMPANIES - FTSE 100

----------

AstraZeneca said "positive" results from its Provent Phase III trial show its AZD7442 treatment "achieved a statistically significant reduction in the incidence of symptomatic Covid-19, the trial's primary endpoint." AZD7442, Astra noted, is a combination of two long-acting antibodies. It reduced the risk of developing symptomatic Covid-19 by 77% compared to a placebo. The trial accrued 25 cases of symptomatic Covid-19 at the primary analysis, and pointed to no cases of severe Covid-19 or Covid-19-related deaths in the trial, versus two deaths from the placebo. "AZD7442 is the first antibody combination, non-vaccine, modified to potentially provide long-lasting protection that has demonstrated prevention of Covid-19 in a clinical trial," Astra said.

----------

COMPANIES - FTSE 250

----------

UK retailer Marks & Spencer said it has made a strong start to its financial year that began on April 4, with improving sales and profit. M&S said the easing of restrictions has led to an "encouraging" performance. In the 19 weeks to August 14, total revenue was up 29% from a year ago, and up 4.4% on the same period in financial 2020, meaning two years ago and before the pandemic began. This has been led by an outperformance in Food sales, which are up 11% on a year ago and up 9.6% on two years ago, with retail park locations trading strongly. Clothing & Home sales are up 92% year-on-year, but are still 2.6% below financial 2020. "The change in our approach to trading, including more focussed ranges, fewer promotions and a substantially smaller summer sale, has resulted in full price sales up about 9% on financial 2020," M&S explained. Looking ahead, M&S expects adjusted pretax profit at the upper end of its guided range of GBP300 million to GBP350 million. "Although there has likely been an element of pent-up consumer demand in trading to date, we believe this performance provides strong confirmation of the beneficial effects of the last 18 months 'Never the Same Again' changes," the retailer added.

----------

COMPANIES - MAIN MARKET AND AIM

----------

Irish building materials firm Kingspan reported a "remarkably strong" first half, with revenue surging on the back of high demand. Pretax profit in the six months to June 30 rose to EUR297.5 million from EUR177.5 million a year before, with trading profit up 64% to EUR329 million. Revenue increased 41% year-on-year to EUR2.92 billion from EUR2.07 billion. Kingspan declared a 19.9 euro cents dividend for the first half, after withholding payment last year. "Despite inflation in our input costs, effective price management has helped increase trading margins, with a stand out performance in our largest division - insulated panels. Our strategy of expanding through acquisition and diversifying geographically has continued, with ten acquisitions made during the period across four continents, and a robust balance sheet positioned to support future growth," Chief Executive Gene Murtagh said.

----------

UK online retail investment platform interactive investor has invited several investment banks to propose an initial public offering in London that could value the company at up to GBP2 billion, Sky News reported Thursday. Sky News reported that the fund supermarket has started pitching a potential 2022 flotation to several banks, although according to bankers a formal decision has yet to be made, and will depend on market conditions. Should a flotation take place, it is likely that the Manchester-based firm would be valued in a range of GBP1.5 billion and GBP2.0 billion. Sky News described ii as the second largest fund supermarket, beaten only by FTSE 100 constituent Hargreaves Lansdown, however, it operates differently by using a flat-fee subscription model. For the six months ended June 30, ii reported a 19% rise in net revenue year-on-year to GBP76.1 million from GBP63.8 million, with a 33% rise in new clients to 31,667.

----------

COMPANIES - GLOBAL

----------

US regulators on Thursday filed a new lawsuit accusing Facebook of maintaining an illegal monopoly in social networking, reviving the case two months after it was dismissed by a federal judge. In the amended complaint, the Federal Trade Commission said Facebook's dominance "is protected by high barriers to entry," and that "even an entrant with a superior product cannot succeed against the overwhelming network effects enjoyed by an incumbent personal social network." The lawsuit filed in federal court in the US capital said Facebook used "anticompetitive acquisitions" of potential rivals such as Instagram and WhatsApp to protect its dominance. FTC officials said the deals amounted to "illegal buy-or-bury" schemes. "Facebook lacked the business acumen and technical talent to survive the transition to mobile. After failing to compete with new innovators, Facebook illegally bought or buried them when their popularity became an existential threat," said acting FTC competition bureau chief Holly Vedova in a statement. The lawsuit, which could take years to go through the courts without a settlement, calls for the court to order "divestiture of assets," including WhatsApp and Instagram, to restore competition.

----------

Aiming for a bigger presence in US brick-and-mortar retail, Amazon.com plans to open "several" multi-purpose shopping venues similar to department stores, the Wall Street Journal reported Thursday. The stores will sell household items, electronics and apparel, showcasing Amazon's private-label merchandise, the newspaper said, citing people familiar with the matter. Some of the first stores are expected in California and Ohio, according to the report. The move would come on the heels of Amazon's 2017 acquisition of the Whole Foods Market grocery chain for USD13.7 billion, which significantly expanded the e-commerce firm's presence in physical retail.

----------

Friday's Shareholder Meetings

Zegona Communications PLC - GM re sale of Euskaltel investment

Auction Technology Group PLC - GM re LiveAuctioneers acquisition

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.